QURE - uniQure N.V.

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Tiptopptrader, Jul 9, 2016.

Tags:
  1. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    4,895
    Likes Received:
    1,125
    uniQure N.V., a biopharmaceutical company, engages in the discovery, development, and commercialization of gene therapies in the Netherlands. The company offers Glybera, a gene therapy product for the treatment of patients with lipoprotein lipase

    [​IMG]
     
    #1 Tiptopptrader, Jul 9, 2016
    leonx81 likes this.
  2. leonx81

    leonx81 Well-Known Member

    Joined:
    Apr 4, 2016
    Messages:
    1,119
    Likes Received:
    563
    Thanks TTT, will put this on my radar.
     
    #2 leonx81, Jul 9, 2016
  3. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    4,895
    Likes Received:
    1,125
    This is not a pick of mine I had only used it and CDE for the contest. I wish had played them as they both went up especially CDE.
     
    #3 Tiptopptrader, Jul 9, 2016
  4. leonx81

    leonx81 Well-Known Member

    Joined:
    Apr 4, 2016
    Messages:
    1,119
    Likes Received:
    563
    Understood and will do my own DD.

    Have a nice weekend.
     
    #4 leonx81, Jul 9, 2016
    Tiptopptrader likes this.
  5. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    2,278
    Likes Received:
    517
    #5 fireopal, Oct 19, 2017
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,609
    Likes Received:
    3,572
    WHAT THE?!?!

    Check out this craziness!
     
    #6 StockJock-e, Oct 20, 2017
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,609
    Likes Received:
    3,572
    Cowen Shines Light on Uniqure NV (QURE) as the Latter Advances Padua Variant AMT-061 into Phase 3

    QURE investors are overwhelmingly excited today after the drug maker announced advancement of AMT-061, a Padua variant FIX AAV5 gene therapy, in hemophilia B, into a pivotal phase 3 trial in 3Q18.
     
    #7 StockJock-e, Oct 20, 2017
  8. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    2,278
    Likes Received:
    517
    #8 fireopal, Oct 24, 2017
  9. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    2,278
    Likes Received:
    517
    #9 fireopal, Oct 25, 2017
(You must log in or sign up to post here.)

Share This Page